Effects of advanced glycation endproducts on the generation of macrophage-mediated oxidized low-density lipoprotein

Journal of Diabetes and its Complications

Volumn 11, Issue 6, 1997, Pages 338-342

  Matsui, Jun ^a   Onuma, Tomio ^b   Tamasawa, Naoki ^a   Suda, Toshihiro ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; GLYCOSYLATED PROTEIN; LIPID HYDROPEROXIDE; LOW DENSITY LIPOPROTEIN;

ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DIABETES MELLITUS; ELECTROPHORETIC MOBILITY; GLYCATION; HUMAN; HUMAN TISSUE; INCUBATION TIME; LIPID COMPOSITION; MACROPHAGE FUNCTION; OXIDATION; PRIORITY JOURNAL;

ANIMALS; CATTLE; ELECTROPHORESIS, AGAR GEL; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; LIPOPROTEINS, LDL; MACROPHAGES, PERITONEAL; MALE; OXIDATION-REDUCTION; RATS; RATS, WISTAR; SERUM ALBUMIN;

EID: 0030668849     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(96)00106-7     Document Type: Article

References (16)

1. Brownlee TJ, Vlassara H, Cerami A: Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med 101:527-537, 1984.
2. Makita Z, Radoff S, Rayfield EJ, Yang Z, Skolnik E, Delaney V, Friedman EA, Cerami A, Vlassara H: Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 325:836-842, 1991.
3. Vlassara H, Brownlee M, Cerami A: High-affinity-receptor-mediated up-take and degradation of glucose-mediated protein: A potential mechanism for removal of senecent macromolecules. Proc Natl Acad Sci USA 82: 5588-5592, 1985.
4. Monnier VM, Kohn RR, Cerami A: Accelerated age-related browning of human collagen in diabetes mellitus. Proc Natl Acad Sci U S A 81:583-587, 1984.
5. Havel RJ, Eder, HA, Bragdon JH: The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34:1345-1353, 1995.
6. Edelson PJ, Cohn ZA: Purification and cultivation of monocytes in macrophages, in In vitro methods in cell-mediated and tumor immunity. Bloom BR, David JR, eds, Academic, New York, 1976:333-340.
7. 2 mimics cell-mediated oxidative modification. J Lipid Res 29:745-753, 1988.
8. Parthasarathy S, Wieland E, Steinberg D: A role for endothelial cell lipoxygenase in low density lipoprotein. Proc Natl Acad Sci U S A 86:1046-1050, 1989.
9. Henriksson P, Hamberg M, Diczfalusy U: Formation of 15-HETE as major hydroxyeicosatetraenoic acid in the atherosclerotic vessel wall Biochim Biophys Acta 834: 272-274, 1985.
10. Yla-Herttula S, Rosenfeld, ME, Parthasarathy S, Glass CK, Sigal E, Witztum JL, Steiberg D: Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc Natl Acad Sci U S A 87:6959-6963, 1990.
11. Brown ML, Jakoubowski JA, Leventis L, Deykin D: Elevated glucose alters eicosanoid release from porcine aortic endothelial cells. J Clin Invest 82:2136-2141, 1988.
12. Nakayama H, Mitsuhasi T, Kuwajima S, Aoki S, Kuroda Y, Itoh T, Nakagawa S: Immunochemical detection of advanced glycation end products in lens crystallins from streptozosin-induccd diabetic rats. Diabetes 42:345-350, 1993.
13. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witzum J: Beyond Cholesterol: Modification of low-density lipoprotein that increase its atherogenisity. N Engl J Med 320:915-924, 1989.
14. Brown MS, Goldstein JL: Lipoprotein metabolism in the macrophages: Implications for cholesterol deposition in atherosclerosis. Ann Rev Biochim 52:223-261, 1983.
15. Schleicher E, Deufel T, Wieland OH: Non-enzymatic glycosylation of human serum lipoproteins. FEBS Lett 129:1-4, 1981.
16. Yamaguchi E, Sato Y, Nishikawa T, Sakai M, Shinohara M, Miyata T, Kobori S, Takeda H, Shichiri M: Study on the effect of glycated lipoprotein on the development of atherosclerosis. J Jpn Diab Soc 36(suppl 1):137, 1993.